1-114684369-CAAAA-CAAA

Variant summary

Our verdict is Likely benign. The variant received -5 ACMG points: 0P and 5B. BP6BS2

The NM_000036.3(AMPD1):​c.382-6delT variant causes a splice region, intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0533 in 889,366 control chromosomes in the GnomAD database, including 3 homozygotes. 1/1 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0031 ( 1 hom., cov: 32)
Exomes 𝑓: 0.062 ( 2 hom. )

Consequence

AMPD1
NM_000036.3 splice_region, intron

Scores

Not classified

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:1B:2

Conservation

PhyloP100: 1.05

Publications

0 publications found
Variant links:
Genes affected
AMPD1 (HGNC:468): (adenosine monophosphate deaminase 1) Adenosine monophosphate deaminase 1 catalyzes the deamination of AMP to IMP in skeletal muscle and plays an important role in the purine nucleotide cycle. Two other genes have been identified, AMPD2 and AMPD3, for the liver- and erythocyte-specific isoforms, respectively. Deficiency of the muscle-specific enzyme is apparently a common cause of exercise-induced myopathy and probably the most common cause of metabolic myopathy in the human. Alternatively spliced transcript variants encoding different isoforms have been identified in this gene.[provided by RefSeq, Feb 2010]
AMPD1 Gene-Disease associations (from GenCC):
  • myopathy due to myoadenylate deaminase deficiency
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • adenosine monophosphate deaminase deficiency
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -5 ACMG points.

BP6
Variant 1-114684369-CA-C is Benign according to our data. Variant chr1-114684369-CA-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 166683.We mark this variant Likely_benign, oryginal submission is: [Conflicting_classifications_of_pathogenicity].
BS2
High Homozygotes in GnomAdExome4 at 2 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
AMPD1NM_000036.3 linkc.382-6delT splice_region_variant, intron_variant Intron 4 of 15 ENST00000520113.7 NP_000027.3 P23109-1
AMPD1NM_001172626.2 linkc.370-6delT splice_region_variant, intron_variant Intron 3 of 14 NP_001166097.2 P23109-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
AMPD1ENST00000520113.7 linkc.382-6delT splice_region_variant, intron_variant Intron 4 of 15 1 NM_000036.3 ENSP00000430075.3 P23109-1

Frequencies

GnomAD3 genomes
AF:
0.00310
AC:
416
AN:
134166
Hom.:
1
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00430
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00408
Gnomad ASJ
AF:
0.00747
Gnomad EAS
AF:
0.000422
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00428
Gnomad MID
AF:
0.0101
Gnomad NFE
AF:
0.00221
Gnomad OTH
AF:
0.00389
GnomAD2 exomes
AF:
0.158
AC:
11192
AN:
70624
AF XY:
0.163
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.183
Gnomad ASJ exome
AF:
0.235
Gnomad EAS exome
AF:
0.147
Gnomad FIN exome
AF:
0.138
Gnomad NFE exome
AF:
0.153
Gnomad OTH exome
AF:
0.170
GnomAD4 exome
AF:
0.0622
AC:
46962
AN:
755166
Hom.:
2
Cov.:
0
AF XY:
0.0623
AC XY:
23216
AN XY:
372814
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0660
AC:
1168
AN:
17690
American (AMR)
AF:
0.0901
AC:
2170
AN:
24072
Ashkenazi Jewish (ASJ)
AF:
0.0977
AC:
1263
AN:
12924
East Asian (EAS)
AF:
0.0723
AC:
1440
AN:
19926
South Asian (SAS)
AF:
0.0692
AC:
2908
AN:
42004
European-Finnish (FIN)
AF:
0.0845
AC:
2449
AN:
28988
Middle Eastern (MID)
AF:
0.0508
AC:
183
AN:
3604
European-Non Finnish (NFE)
AF:
0.0577
AC:
33188
AN:
575086
Other (OTH)
AF:
0.0710
AC:
2193
AN:
30872
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0.000000), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.249
Heterozygous variant carriers
0
7777
15554
23330
31107
38884
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1090
2180
3270
4360
5450
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00311
AC:
417
AN:
134200
Hom.:
1
Cov.:
32
AF XY:
0.00340
AC XY:
220
AN XY:
64742
show subpopulations
African (AFR)
AF:
0.00429
AC:
157
AN:
36602
American (AMR)
AF:
0.00407
AC:
54
AN:
13258
Ashkenazi Jewish (ASJ)
AF:
0.00747
AC:
24
AN:
3212
East Asian (EAS)
AF:
0.000424
AC:
2
AN:
4718
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4192
European-Finnish (FIN)
AF:
0.00428
AC:
33
AN:
7710
Middle Eastern (MID)
AF:
0.0145
AC:
4
AN:
276
European-Non Finnish (NFE)
AF:
0.00221
AC:
136
AN:
61600
Other (OTH)
AF:
0.00386
AC:
7
AN:
1814
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.458
Heterozygous variant carriers
0
17
34
50
67
84
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0914
Hom.:
0

ClinVar

Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:2
Revision: criteria provided, conflicting classifications
LINK: link

Submissions by phenotype

Muscle AMP deaminase deficiency Uncertain:1Benign:1
Jan 29, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
Dec 18, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.0
Mutation Taster
=97/3
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs727503806; hg19: chr1-115226990; COSMIC: COSV62415560; API